Mealey's (January 28, 2020, 1:18 PM EST) -- ALEXANDRIA, Va. — In a Jan. 24 preliminary response, the Regents of the University of Minnesota (Minnesota) argues that the Patent Trial and Appeal Board should reject a request for inter partes review (IPR) of the university’s patent that claims a genus of compounds useful in the treatment of certain viruses and cancers (Gilead Sciences Inc. v. Regents of the University of Minnesota, No. IPR2017-01753, PTAB)....